Ivermectin now against COVID-19, why…
Ivermectin is the new hydroxychloroquine. But who is its new Raoult? What if the cast of the 2021 sequel will remain otherwise the same?
Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
Ivermectin is the new hydroxychloroquine. But who is its new Raoult? What if the cast of the 2021 sequel will remain otherwise the same?
Macchiarini’s victim Paloma Cabeza speaks out again, fearing she doesn’t have much time left. She appeals to the Swedish prosecutor for justice in the deadly trachea transplant scandal.
It was only logical that COVID-19 will be cured with vitamin supplements. Peer-reviewed science is now catching up with the bustling Vitamin D market.
St Carlos of Oviedo almost was canonised as Spain’s first living martyr, but now Nature revoked his mentoring award. Spanish media and science elites are desperate, even the Queen is not amused. The Royal Academy of Sciences insists Lopez-Otin is a victim of journal’s failure.
Spain is where dishonest research gets rewarded, with awards, grants and media fame. No wonder the New York-based immunologist Andrea Cerutti opened a second lab in Barcelona.
I obtained a partial script of a stage play which recently premiered in Paris: “La Passion de Don Carlos”. Any similarities with Spanish or French cancer researchers are entirely coincidental.
Carlos Lopez-Otin was forced to retract EIGHT papers in the Journal of Biological Chemistry, right after he retracted a very important paper in Nature Cell Biology. Spanish elites cry foul, a letter signed by 50 Spanish researchers was sent to JBC to prevent retractions. The ringleader is Juan Valcarcel of CRG in Barcelona, and I release 3 incompetent investigative reports Valcarcel commissioned in 2015 to whitewash his CRG colleague Maria Pia Cosma.
The 2015 Nature Cell Biology paper by the Spanish cancer researcher Carlos Lopez-Otin and his US partner George Q Daley, stem cell titan and dean of Harvard Medical School, is being retracted. First author and Lopez-Otin’s student Clara Soria-Valles caused Daley even more trouble: her next groundbreaking paper was meant to be already published, but it is not even submitted and might never be.
Following my reporting, the cancer researcher Carlos López-Otín abandoned his ERC-funded 36-member-strong “Degradome” lab at the University of Oviedo in Spain and moved in with his collaborator in Paris, France, Guido Kroemer. Yet Lopez-Otin’s data integrity issues seem as poppycock compared to what Kroemer and his life partner Laurence Zitvogel dished out to the scientific community.
Elite journal Nature Cell Biology (NCB) requests deposition of raw data, in particular original scans of western blots and other gel analyses. Spanish star cancer researcher Carlos López-Otín, winner of 2017 Nature Mentoring Award, instead deposited whatever odd gel picture his lab had available, counting that nobody will bother to check. Yet readers did.